Tandem Diabetes Care (TNDM) Interest & Investment Income (2013 - 2025)
Tandem Diabetes Care's (TNDM) quarterly Interest & Investment Income came in at $4.2 million in Q1 2025, down 21.1% YoY from $5.3 million in Q1 2024, and down 7.05% on a QoQ basis from $4.5 million in Q4 2024.
Tandem Diabetes Care (TNDM) Interest & Investment Income (2013 - 2025) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Interest & Investment Income data on file, last reported at $4.2 million in Q1 2025.
- Quarterly Interest & Investment Income fell 21.1% year-over-year to $4.2 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $16.9 million (down 24.36% YoY) and the FY2024 annual result came in at $18.0 million, down 21.28% from the prior year.
- Interest & Investment Income declined to $4.2 million in Q1 2025, from $4.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $5.9 million in Q1 2023 to a low of -$47000.0 in Q4 2021.
- A 5-year average of $3.0 million and a median of $3.1 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income sank 114.16% — and 2022, when it jumped 6687.23%.
- Tracing TNDM's Interest & Investment Income over 5 years: stood at -$47000.0 in 2021, then jumped by 6687.23% to $3.1 million in 2022, then surged by 79.36% to $5.6 million in 2023, then slipped by 18.76% to $4.5 million in 2024, then slipped by 7.05% to $4.2 million in 2025.
- The last three Interest & Investment Income figures came in at $4.2 million (Q1 2025), $4.5 million (Q4 2024), and $5.3 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | Tandem Diabetes Care | 1.58 Bn | 1.12 Bn | 144.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 5.34 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 5.31 Mn |
| Dec 31, 2023 | 5.55 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 5.87 Mn |
| Dec 31, 2022 | 3.10 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 826,000.00 |
| Mar 31, 2022 | 415,000.00 |
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Jun 30, 2021 | 418,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 143,000.00 |
| Jun 30, 2020 | 367,000.00 |